Stocks › EXAS
EXAS
EXAS·USD
—
No end-of-day price on record
EXAS
EXAS
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
EXASS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of EXAS by members of U.S. Congress · 32 on record · 1 in the last 12 months
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Kevin HernHouse · R · OK |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Apr 3, 2026 | Mar 24, 2026 | Filing ↗ |
 Josh GottheimerHouse · D · NJ |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Jun 8, 2024 | May 10, 2024 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Mar 7, 2024 | Feb 1, 2024 | Filing ↗ |
| Kevin HernHouse · R · OK |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Feb 11, 2024 | Jan 2, 2024 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Dec 8, 2023 | Nov 13, 2023 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
EXASEXAS · Stock |
Purchase $1,001 - $15,000 |
Nov 11, 2023 | Oct 16, 2023 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Oct 15, 2023 | Sep 15, 2023 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Jun 11, 2023 | May 1, 2023 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
EXASEXAS · Stock |
Purchase $1,001 - $15,000 |
Feb 17, 2023 | Jan 20, 2023 | Filing ↗ |
| Kevin HernHouse · R · OK |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Feb 14, 2023 | Jan 31, 2023 | Filing ↗ |
| Kevin HernHouse · R · OK |
EXASEXAS · Stock |
Sale $50,001 - $100,000 |
Jan 13, 2023 | Dec 19, 2022 | Filing ↗ |
| Kevin HernHouse · R · OK |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Jun 14, 2022 | May 16, 2022 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Jul 15, 2021 | Jun 3, 2021 | Filing ↗ |
| Kevin HernHouse · R · OK |
EXASEXAS · Stock |
Purchase $1,001 - $15,000 |
Jun 15, 2021 | May 20, 2021 | Filing ↗ |
| Kevin HernHouse · R · OK |
EXASEXAS · Stock |
Purchase $1,001 - $15,000 |
Jun 15, 2021 | May 20, 2021 | Filing ↗ |
| Kevin HernHouse · R · OK |
EXASEXAS · Stock |
Purchase $1,001 - $15,000 |
Jun 15, 2021 | May 20, 2021 | Filing ↗ |
| Kevin HernHouse · R · OK |
EXASEXAS · Stock |
Purchase $50,001 - $100,000 |
Jun 15, 2021 | May 20, 2021 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
EXASEXAS · Stock |
Purchase $1,001 - $15,000 |
Dec 9, 2020 | Nov 11, 2020 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
EXASEXAS · Stock |
Purchase $1,001 - $15,000 |
Nov 5, 2020 | Oct 26, 2020 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Oct 13, 2020 | Sep 15, 2020 | Filing ↗ |
| Kevin HernHouse · R · OK |
EXASEXAS · Stock |
Purchase $1,001 - $15,000 |
Aug 15, 2020 | Jul 27, 2020 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Jul 9, 2020 | Jun 5, 2020 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Jul 9, 2020 | Jun 2, 2020 | Filing ↗ |
 Donna ShalalaHouse · D · FL |
EXASEXAS · Stock |
Sale $1,001 - $15,000 |
Apr 27, 2020 | Jun 24, 2019 | Filing ↗ |
| Donna ShalalaHouse · D · FL |
EXASEXAS · Stock |
Purchase $1,001 - $15,000 |
Apr 27, 2020 | Jun 19, 2019 | Filing ↗ |
Whale Activity
Institutional 13F positions
No 13F positions in EXAS among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by EXAS insiders, by quarter · Form 4
Recent Insider Transactions
1,359 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Baranick BrianEVP, GM, Precision Oncology | Disposition to issuer | −795 | — | — | Mar 23, 2026 | Form 4 ↗ |
| Baranick BrianEVP, GM, Precision Oncology | Disposition to issuer | −137.2K | — | — | Mar 23, 2026 | Form 4 ↗ |
| Baranick BrianEVP, GM, Precision Oncology | Grant / award | +33.3K | $0.00 | $0 | Mar 23, 2026 | Form 4 ↗ |
| Herriott JamesSVP, General Counsel & Sec | Disposition to issuer | −1,762 | — | — | Mar 23, 2026 | Form 4 ↗ |
| Herriott JamesSVP, General Counsel & Sec | Disposition to issuer | −68.2K | — | — | Mar 23, 2026 | Form 4 ↗ |
| Bloomer AaronEVP, Chief Financial Officer | Disposition to issuer | −417 | — | — | Mar 23, 2026 | Form 4 ↗ |
| Bloomer AaronEVP, Chief Financial Officer | Disposition to issuer | −138.7K | — | — | Mar 23, 2026 | Form 4 ↗ |
| Bloomer AaronEVP, Chief Financial Officer | Grant / award | +89.9K | $0.00 | $0 | Mar 23, 2026 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Disposition to issuer | −6,368 | — | — | Mar 23, 2026 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Disposition to issuer | −191.9K | — | — | Mar 23, 2026 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Grant / award | +60.4K | $0.00 | $0 | Mar 23, 2026 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Disposition to issuer | −117.4K | — | — | Mar 23, 2026 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Disposition to issuer | −86.8K | — | — | Mar 23, 2026 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Disposition to issuer | −46.5K | — | — | Mar 23, 2026 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Disposition to issuer | −29.1K | — | — | Mar 23, 2026 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Disposition to issuer | −1.4M | — | — | Mar 23, 2026 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Grant / award | +119.3K | $0.00 | $0 | Mar 23, 2026 | Form 4 ↗ |
| ORVILLE JACOB AEVP, GM, Screening | Disposition to issuer | −1,774 | — | — | Mar 23, 2026 | Form 4 ↗ |
| ORVILLE JACOB AEVP, GM, Screening | Disposition to issuer | −153.7K | — | — | Mar 23, 2026 | Form 4 ↗ |
| ORVILLE JACOB AEVP, GM, Screening | Grant / award | +53.3K | $0.00 | $0 | Mar 23, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding EXAS · SEC Form N-PORT
Funds report their holdings by CUSIP, and EXAS could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming EXAS as client
No lobbying filings found naming EXAS as the client.
Government Contracts
Federal awards to EXAS · USAspending
No federal contract awards found for EXAS.
U.S. Patents
Recent USPTO applications naming EXAS
No USPTO patent applications found for EXAS.
Annual Financials
From EXAS's 10-K filings · XBRL
No annual XBRL figures on record for EXAS. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No price history on record for EXAS.
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About EXAS
From SEC EDGAR company records
No company profile on record.